These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38696259)

  • 1. Verteporfin inhibits TGF-β signaling by disrupting the Smad2/3-Smad4 interaction.
    Nong J; Shen S; Hong F; Xiao F; Meng L; Li P; Lei X; Chen YG
    Mol Biol Cell; 2024 Jul; 35(7):ar95. PubMed ID: 38696259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
    Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
    Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the gene transcription and apoptosis mediated by TGF-beta-Smad2/3-Smad4 signaling.
    Yu J; Zhang L; Chen A; Xiang G; Wang Y; Wu J; Mitchelson K; Cheng J; Zhou Y
    J Cell Physiol; 2008 May; 215(2):422-33. PubMed ID: 17960585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer.
    Tong X; Wang S; Lei Z; Li C; Zhang C; Su Z; Liu X; Zhao J; Zhang HT
    Oncogene; 2020 Apr; 39(14):2890-2904. PubMed ID: 32029901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
    Huang G; Du MY; Zhu H; Zhang N; Lu ZW; Qian LX; Zhang W; Tian X; He X; Yin L
    Biomed Pharmacother; 2018 Oct; 106():217-224. PubMed ID: 29960168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition.
    Lin H; Li N; He H; Ying Y; Sunkara S; Luo L; Lv N; Huang D; Luo Z
    Mol Pharmacol; 2015 Dec; 88(6):1062-71. PubMed ID: 26424816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.
    Zhang J; Thorikay M; van der Zon G; van Dinther M; Ten Dijke P
    J Vis Exp; 2020 Oct; (164):. PubMed ID: 33191940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMAD3 and SMAD4 have a more dominant role than SMAD2 in TGFβ-induced chondrogenic differentiation of bone marrow-derived mesenchymal stem cells.
    de Kroon LM; Narcisi R; van den Akker GG; Vitters EL; Blaney Davidson EN; van Osch GJ; van der Kraan PM
    Sci Rep; 2017 Feb; 7():43164. PubMed ID: 28240243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes.
    Grönroos E; Kingston IJ; Ramachandran A; Randall RA; Vizán P; Hill CS
    Mol Cell Biol; 2012 Jul; 32(14):2904-16. PubMed ID: 22615489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGF
    Du H; Gu J; Peng Q; Wang X; Liu L; Shu X; He Q; Tan Y
    Oxid Med Cell Longev; 2021; 2021():2337818. PubMed ID: 34712379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-β1/Smad signaling pathways.
    Li T; Zhao N; Lu J; Zhu Q; Liu X; Hao F; Jiao X
    Bioengineered; 2019 Dec; 10(1):282-291. PubMed ID: 31311401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGS6 suppresses TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancers via a novel mechanism dependent on its interaction with SMAD4.
    Wang Z; Chen J; Wang S; Sun Z; Lei Z; Zhang HT; Huang J
    Cell Death Dis; 2022 Jul; 13(7):656. PubMed ID: 35902557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Associated Macrophages Derived TGF-β‒Induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells through Smad2,3-4/Snail Signaling Pathway.
    Cai J; Xia L; Li J; Ni S; Song H; Wu X
    Cancer Res Treat; 2019 Jan; 51(1):252-266. PubMed ID: 29690747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing Smad2/3-, STAT3- and β-catenin-mediated epithelial-mesenchymal transition.
    Xu S; Zhang ZH; Fu L; Song J; Xie DD; Yu DX; Xu DX; Sun GP
    Cancer Sci; 2020 Jan; 111(1):59-71. PubMed ID: 31729097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of TGF-β signaling at the nuclear envelope: characterization of interactions between MAN1, Smad2 and Smad3, and PPM1A.
    Bourgeois B; Gilquin B; Tellier-Lebègue C; Östlund C; Wu W; Pérez J; El Hage P; Lallemand F; Worman HJ; Zinn-Justin S
    Sci Signal; 2013 Jun; 6(280):ra49. PubMed ID: 23779087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDZK1-interacting protein 1 (PDZK1IP1) traps Smad4 protein and suppresses transforming growth factor-β (TGF-β) signaling.
    Ikeno S; Nakano N; Sano K; Minowa T; Sato W; Akatsu R; Sakata N; Hanagata N; Fujii M; Itoh F; Itoh S
    J Biol Chem; 2019 Mar; 294(13):4966-4980. PubMed ID: 30718277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
    Thacker PC; Karunagaran D
    PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prohaptoglobin inhibits the transforming growth factor-β-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells.
    Oh MK; Joo H; Kim IS
    PLoS One; 2022; 17(5):e0266409. PubMed ID: 35580109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo.
    Sakairi T; Hiromura K; Takahashi S; Hamatani H; Takeuchi S; Tomioka M; Maeshima A; Kuroiwa T; Nojima Y
    Nephrology (Carlton); 2011 Jan; 16(1):76-86. PubMed ID: 21175982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous hydrogen sulfide donor NaHS alleviates nickel-induced epithelial-mesenchymal transition and the migration of A549 cells by regulating TGF-β1/Smad2/Smad3 signaling.
    Ye M; Yu M; Yang D; Li J; Wang H; Chen F; Yu H; Shen T; Zhu Q; Zhou C
    Ecotoxicol Environ Saf; 2020 Jun; 195():110464. PubMed ID: 32171946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.